CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY) (USD $)	Common Stock	Paid-In Capital	Stock Subscription Receivable	Accumulated Comprehensive Loss	Deficit Accumulated during the Exploration Stage	Total Stockholders' Equity (Deficiency)
Balance at Jul. 27, 2009
Issuance of founders' stock	$ 7,301	$ (5,901)				$ 1,400
Issuance of founders' stock (in Shares)	7,300,667
Sale of common stock	880	459,120	(50,000)			410,000
Sale of common stock (in Shares)	880,000
Stock issuance costs		(40,825)				(40,825)
Common stock issued to investors in a debt offering	822	410,260				411,082
Common stock issued to investors in a debt offering (in Shares)	822,000
Shares issued for stock offering services	33	30,792				30,825
Shares issued for stock offering services (in Shares)	33,333
Employee stock based compensation (benefit)		64,941				64,941
Net Loss					(2,015,490)	(2,015,490)
Balance at Dec. 31, 2009	9,036	918,387	(50,000)		(2,015,490)	(1,138,067)
Balance - Shares at Dec. 31, 2009	9,036,000
Sale of common stock	1,282	655,218	50,000			706,500
Sale of common stock (in Shares)	1,282,005
Stock issuance costs		(12,160)				(12,160)
Employee stock based compensation (benefit)		40,990				40,990
Net Loss					(2,503,388)	(2,503,388)
Balance at Dec. 31, 2010	10,318	1,602,435			(4,518,878)	(2,906,125)
Balance - Shares at Dec. 31, 2010	10,318,002
Sale of common stock	6,858	1,742,717				1,749,575
Sale of common stock (in Shares)	6,857,538
Stock issuance costs		(111,775)				(111,775)
Shares issued for stock offering services	1,698	(1,698)
Shares issued for stock offering services (in Shares)	1,698,318
Employee stock based compensation (benefit)		(53,336)				(53,336)
Net Loss					(2,389,139)	(2,389,139)
Common stock issued for accrued interest conversion of 8% convertible promissory notes	64	76,747				76,811
Common stock issued for accrued interest conversion of 8% convertible promissory notes (in Shares)	64,009
Common stock issued upon conversion of 8% convertible promissory notes	514	615,986				616,500
Common stock issued upon conversion of 8% convertible promissory notes (in Shares)	513,750
Common stock issued upon conversion of 9% convertible promissory notes	1,458	436,042				437,500
Common stock issued upon conversion of 9% convertible promissory notes (in Shares)	1,458,333
Common stock issued for accrued interest upon conversion of note sold to an outside investor	160	39,840				40,000
Common stock issued for accrued interest upon conversion of note sold to an outside investor (in Shares)	160,000
Common stock issued upon conversion of a note sold to an outside investor	400	99,600				100,000
Common stock issued upon conversion of a note sold to an outside investor (in Shares)	400,000
Common stock issued to founders upon conversion of Trunity, LLC note	7,200	1,792,800				1,800,000
Common stock issued to founders upon conversion of Trunity, LLC note (in Shares)	7,200,000
Common stock issued upon conversion of lines of credit with founders	3,972	989,028				993,000
Common stock issued upon conversion of lines of credit with founders (in Shares)	3,972,000
Balance at Dec. 31, 2011	32,642	7,228,386			(6,908,017)	353,011
Balance - Shares at Dec. 31, 2011	62,641,953
Sale of common stock	3,164	943,157				946,321
Sale of common stock (in Shares)	3,164,479
Employee stock based compensation (benefit)		226,807				226,807
Net Loss					(2,428,483)	(2,428,483)
Reverse recapitalization related to acquisition	325	(325,325)				(325,000)
Reverse recapitalization related to acquisition (in Shares)	325,000
Warrants issued for services		37,453				37,453
Debt beneficial conversion feature, net of issuance costs		295,004				295,004
Foreign currency translation loss				(8,299)		(8,299)
Balance at Dec. 31, 2201	$ 36,131	$ 8,405,482		$ (8,299)	$ (9,336,500)	$ (903,186)
Balance - Shares at Dec. 31, 2201	36,131,432